Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06298084
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2024-02-12
Brief Title:
Dose-Expansion Modular Study To Explore the Safety Tolerability and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer ABC After Progression on T-DXd
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Organization Data
Organization:
Gustave Roussy Cancer Campus Grand Paris
Class:
OTHER
Study ID:
2023-505925-15-00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Daiichi Sankyo | INDUSTRY |